Lori Taylor

Company: Annexon Biosciences

Job title: Senior Vice President of Portfolio Strategy

Seminars:

Working With Regulators: Designing Trials That Lead to Approval 9:30 am

Share strategies for successful regulatory engagement throughout the full development timeline from pre-IND to BLA/NDA submission Tools for managing international trial variability Reflections on regulatory engagement strategy across trial phases Debate future directions in regulatory science to better accommodate novel endpoints, combination therapies, and precision medicine approaches in dry AMDRead more

day: Day2

Rethinking Endpoints: How Lesion Location Drives Clinically Meaningful Measures of Impact in Dry AMD 11:30 am

Understanding why lesion location, not just size or growth, is emerging as a more meaningful predictor of vision-threatening progression in dry AMD Discuss how spatial distribution of atrophy may influence endpoint sensitivity, patient stratification, and the interpretation of therapeutic benefit. Sharing insights from clinical data on spatial lesion impact to refine trial endpoints and improve outcome relevanceRead more

day: Day1